Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,909,062
-
Share change
-
+3,639,372
-
Total reported value
-
$227,190,055
-
Put/Call ratio
-
8.2%
-
Price per share
-
$6.70
-
Number of holders
-
80
-
Value change
-
+$25,572,223
-
Number of buys
-
49
-
Number of sells
-
26
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q3 2022
As of 30 Sep 2022,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,909,062 shares.
The largest 10 holders included
BVF INC/IL, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Nantahala Capital Management, LLC, Kynam Capital Management, LP, INGALLS & SNYDER LLC, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, Parkman Healthcare Partners LLC, and CITADEL ADVISORS LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.